Next Article in Journal
Formulation of Chitosan-Coated Brigatinib Nanospanlastics: Optimization, Characterization, Stability Assessment and In-Vitro Cytotoxicity Activity against H-1975 Cell Lines
Next Article in Special Issue
Special Issue “GPCRs: Ligands and beyond 2022”
Previous Article in Journal
Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial
Previous Article in Special Issue
Ligands and Beyond: Mechanosensitive Adhesion GPCRs
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(3), 346; https://doi.org/10.3390/ph15030346
Action Date Notes Link
article pdf uploaded. 11 March 2022 14:39 CET Version of Record https://www.mdpi.com/1424-8247/15/3/346/pdf-vor
article supplementary file uploaded. 11 March 2022 14:39 CET - https://www.mdpi.com/1424-8247/15/3/346#supplementary
article xml file uploaded 14 March 2022 06:41 CET Original file -
article xml uploaded. 14 March 2022 06:41 CET Update https://www.mdpi.com/1424-8247/15/3/346/xml
article pdf uploaded. 14 March 2022 06:41 CET Updated version of record https://www.mdpi.com/1424-8247/15/3/346/pdf
article html file updated 14 March 2022 06:43 CET Original file -
article html file updated 1 August 2022 05:17 CEST Update https://www.mdpi.com/1424-8247/15/3/346/html
Back to TopTop